Correction to: Nature Communications https://doi.org/10.1038/s41467-023-37211-7, published online 27 March 2023
In the Acknowledgements section of this article, the grant number relating to US National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium given for Li Ding was incorrectly given as U24CA210976 and should have been U24CA210972. The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wu, Y., Terekhanova, N.V., Caravan, W. et al. Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma. Nat Commun 14, 2817 (2023). https://doi.org/10.1038/s41467-023-38561-y
Published:
DOI: https://doi.org/10.1038/s41467-023-38561-y
This article is cited by
-
Spatiotemporal multi-omics: exploring molecular landscapes in aging and regenerative medicine
Military Medical Research (2024)